Anthropic Deploys Claude AI to Accelerate Drug Discovery and Biotech Research
Anthropic is expanding Claude's application into drug discovery, antibody development, and clinical research through direct partnerships with biotech firms.
Category
Search Results for
Latest stories, in-depth analysis & breaking updates
6+
Articles
Palantir Cofounder Backs US Monkey Farm Plan as AI Drives Up Macaque Prices
A US startup backed by Palantir cofounder Joe Lonsdale aims to build a 30,000-capacity macaque breeding facility as AI drug discovery and export bans squeeze laboratory supplies.
The Hidden Risk: How Weight-Loss Drugs May Fuel Eating Disorders
As prescriptions for GLP-1 receptor agonists soar globally, clinicians express growing concern over their potential impact on vulnerable patients struggling with disordered eating.
Bioengineers Design Synthetic Therapeutics Using Egg Protein Scaffolds
Researchers have developed a novel drug delivery mechanism utilizing modified egg proteins to transport complex therapeutics directly to targeted tissues.
How Free Meals From Pharma Companies Shape Doctor Prescriptions
A comprehensive new review reveals a direct correlation between pharmaceutical-funded meals and increased prescriptions for specific medications.
Yosemite Venture Firm Targets Cancer with AI-Driven Biotech
Reed Jobs's venture firm, Yosemite, has rapidly expanded its operations, leveraging artificial intelligence to accelerate biotech discoveries, particularly in cancer research. The firm is capitalizing...
